Liraglutide suppresses the proliferation of endometrial cancer cells through the adenosine 5′-monophosphate (AMP)-activated protein kinase signaling pathway

Detalles Bibliográficos
Autores principales: Zhu, Xin-Xin, Feng, Zong-Hao, Liu, Lin-Zhi, Zhang, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Clinical Observations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7929608/
https://www.ncbi.nlm.nih.gov/pubmed/33470656
http://dx.doi.org/10.1097/CM9.0000000000001363
_version_ 1783659947284758528
author Zhu, Xin-Xin
Feng, Zong-Hao
Liu, Lin-Zhi
Zhang, Yan
author_facet Zhu, Xin-Xin
Feng, Zong-Hao
Liu, Lin-Zhi
Zhang, Yan
author_sort Zhu, Xin-Xin
collection PubMed
description
format Online
Article
Text
id pubmed-7929608
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-79296082021-03-05 Liraglutide suppresses the proliferation of endometrial cancer cells through the adenosine 5′-monophosphate (AMP)-activated protein kinase signaling pathway Zhu, Xin-Xin Feng, Zong-Hao Liu, Lin-Zhi Zhang, Yan Chin Med J (Engl) Clinical Observations Lippincott Williams & Wilkins 2021-03-05 2021-01-19 /pmc/articles/PMC7929608/ /pubmed/33470656 http://dx.doi.org/10.1097/CM9.0000000000001363 Text en Copyright © 2021 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0
spellingShingle Clinical Observations
Zhu, Xin-Xin
Feng, Zong-Hao
Liu, Lin-Zhi
Zhang, Yan
Liraglutide suppresses the proliferation of endometrial cancer cells through the adenosine 5′-monophosphate (AMP)-activated protein kinase signaling pathway
title Liraglutide suppresses the proliferation of endometrial cancer cells through the adenosine 5′-monophosphate (AMP)-activated protein kinase signaling pathway
title_full Liraglutide suppresses the proliferation of endometrial cancer cells through the adenosine 5′-monophosphate (AMP)-activated protein kinase signaling pathway
title_fullStr Liraglutide suppresses the proliferation of endometrial cancer cells through the adenosine 5′-monophosphate (AMP)-activated protein kinase signaling pathway
title_full_unstemmed Liraglutide suppresses the proliferation of endometrial cancer cells through the adenosine 5′-monophosphate (AMP)-activated protein kinase signaling pathway
title_short Liraglutide suppresses the proliferation of endometrial cancer cells through the adenosine 5′-monophosphate (AMP)-activated protein kinase signaling pathway
title_sort liraglutide suppresses the proliferation of endometrial cancer cells through the adenosine 5′-monophosphate (amp)-activated protein kinase signaling pathway
topic Clinical Observations
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7929608/
https://www.ncbi.nlm.nih.gov/pubmed/33470656
http://dx.doi.org/10.1097/CM9.0000000000001363
work_keys_str_mv AT zhuxinxin liraglutidesuppressestheproliferationofendometrialcancercellsthroughtheadenosine5monophosphateampactivatedproteinkinasesignalingpathway
AT fengzonghao liraglutidesuppressestheproliferationofendometrialcancercellsthroughtheadenosine5monophosphateampactivatedproteinkinasesignalingpathway
AT liulinzhi liraglutidesuppressestheproliferationofendometrialcancercellsthroughtheadenosine5monophosphateampactivatedproteinkinasesignalingpathway
AT zhangyan liraglutidesuppressestheproliferationofendometrialcancercellsthroughtheadenosine5monophosphateampactivatedproteinkinasesignalingpathway

Ejemplares similares